Picture of CStone Pharmaceuticals logo

2616 CStone Pharmaceuticals Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for CStone Pharmaceuticals, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1,793-2,308-1,221-1,920-903
Depreciation
Amortisation
Non-Cash Items969980512349173
Unusual Items
Other Non-Cash Items
Changes in Working Capital27.923618664.572.6
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-791-1,081-508-1,484-612
Capital Expenditures-7.91-10.4-71.4-149-102
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-370-6481,252-677467
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-378-6591,181-827365
Financing Cash Flow Items-2.3-102-1.32-2.24-11.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1,6622,0911,38992.328.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash6184251,898-2,282-184